Data Driven Utilization Management, Purpose Built for Oncology
Oncology Analytics® provides health plans, providers, and patients with a data-driven, utilization management solution that delivers real-world, evidence-based analytics focused exclusively for oncology
Oncology Analytics Raises $21 Million Series B Financing Led by Oak HC/FT
Prominent healthcare investor Oak HC/FT joined by McKesson Ventures, Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund to Accelerate Patient-First Oncology Benefits Management
Today’s cancer treatments are varied, complicated and costly. Oncology treatment costs are soaring and forecast to hit $105 billion in the US by 2023, driven primarily by availability and favorable reimbursement of new medicines.
Oncology Analytics provides the critical missing link for health plans by helping to manage the total cost of cancer care. By providing access to current, evidence-based, disease-specific analytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, health plans are able to provide their members with the ability to achieve the best possible outcomes.
Improved outcomes are possible when treatment options are tailored to the unique needs of the patient. Ensuring that patients receive the optimal treatment that balances efficacy, toxicity and affordability lie at the heart of Oncology Analytics’ mission.
Utilization Management, Purpose Built for Oncology
The Oncology Analytics e-Prior Authorization platform is purpose-built for oncology to efficiently evaluate and approve high-quality and high-value treatments for cancer care.
Company achieves 100% score on policies, procedures, and file reviewread more
Former Optum executive joins oncology benefits management and analytics company to accelerate growthread more
Oncology Analytics, Inc. Launches Comprehensive User-Friendly Clinical Decision Support Tool for Molecular & Genetic Testing
In response to the thousands of genetic and molecular tests being marketed, which consequently inundate health plans with reimbursement and policy coverage decisions, Oncology Analytics, Inc. has launched a clinical decision support tool for molecular and genetic...read more
Articles & Press
The new funding will help expand the company’s oncology benefits management capabilities and invest in new technology.read more
The financing news comes on the heels of the company moving its headquarters to Atlanta from Plantation, Florida as a way to accommodate its rapid growth and tap into the technical and clinical talent in the region.read more